Isoetharine mesylate salt
SIGMA/I3639
Synonym: 4-
CAS Number: 7279-75-6
Empirical Formula (Hill Notation): C13H21NO3 · CH4O3S
Molecular Weight: 335.42
EC Number: 230-695-8
MDL Number: MFCD00133422
Linear Formula: C13H21NO3 · CH4O3S
Product Type: Chemical
| InChI | 1S/C13H21NO3.CH4O3S/c1-4- |
| InChI key | SOYAGMVKMXZVNZ-UHFFFAOYSA |
| originator | Sanofi Aventis |
| Quality Level | 200 ![]() |
| SMILES string | CS(O)(=O)=O.CCC(NC(C)C)C( |
| storage temp. | 2-8°C |
| Application: | Isoetharine mesylate salt has been used: • as an adrenergic drug to test its effect on embryo implantation in 4-day pregnant mice • as a substrate for recombinant human sulfotransferase (SULT) in SULT assay to monitor conjugation reaction • as a β-2 agonist in collision-induced dissociation (CID) mass spectrometry analysis |
| Biochem/physiol Actions: | Isoetharine is an agonist for β-adrenergic receptors and is a bronchodilator. It is a catecholic drug metabolized by sulfotransferases and is present in human urine and plasma as a sulfated metabolite. Catechol O-methyltransferase (COMT) also mediates the methylation of isoetharine in the metabolic conjugation pathway. |
| Features and Benefits: | This compound was developed by Sanofi Aventis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1 g in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 |
| Precautionary statements | P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


